Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Shengli Xue"'
Autor:
Jialing Lu, Xiebing Bao, Jihao Zhou, Xiaoli Li, Zhewei He, Yujie Ji, Shengli Xue, Suning Chen, Depei Wu, Qi Hu, Peng Ke, Xiao Ma
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-5 (2024)
Externí odkaz:
https://doaj.org/article/2f05afe91ee142658d5d3e3bf9702176
Autor:
Lu Gao, Li Yang, Shiyuan Zhou, Wenjuan Zhu, Yue Han, Suning Chen, Shengli Xue, Ying Wang, Huiying Qiu, Depei Wu, Xiaojin Wu
Publikováno v:
Stem Cell Research & Therapy, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract Background Elderly patients with acute myeloid leukemia or myelodysplastic syndromes (AML/MDS) have historically had poor prognoses. However, there has been a recent increase in the use of allogenic hematopoietic stem cell transplantation (a
Externí odkaz:
https://doaj.org/article/deae602c27b0440ab606e46d96bb3708
Autor:
Keyuan Zhang, Xiang Zhang, Yang Xu, Shengli Xue, Huiying Qiu, Xiaowen Tang, Yue Han, Suning Chen, Aining Sun, Yanming Zhang, Depei Wu, Ying Wang
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/78fb612bf3ea4575bc3dcb75963238c6
Autor:
Zhenzhen Yao, Bin Gu, Jia Chen, Yang Xu, Feng Chen, Shengli Xue, Huiying Qiu, Xiaowen Tang, Yue Han, Suning Chen, Aining Sun, Lei Yu, Yanming Zhang, Depei Wu, Ying Wang
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/ee57aad56f824923ad200cbd4f8201f0
Autor:
Zhiyou Yu, Yao Yao, Yanming Zhang, Jia Chen, Yang Xu, Shengli Xue, Huiying Qiu, Xiaowen Tang, Yue Han, Suning Chen, Aining Sun, Depei Wu, Ying Wang
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTAdult patients with newly diagnosed de novo acute myeloid leukemia (AML), who had less than a 50% reduction in blast numbers and with > 15% residual blasts after first cycle of induction chemotherapy, defined as type 1 primary refractory (REF
Externí odkaz:
https://doaj.org/article/380bf51d48094ab8bdc54edfbf1911f2
Autor:
Sining Liu, Xinyue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Shengli Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, Depei Wu, Qingya Cui, Xiaowen Tang
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract CD19 chimeric antigen receptor (CAR) T-cell therapy has shown great success against B-cell acute lymphoblastic leukemia (B-ALL). Tandem and sequential CD19/CD22 dual-target CAR T-cell therapies have been developed to reduce the possibility o
Externí odkaz:
https://doaj.org/article/d4a649a07d8c45979485a8ee58bdd152
Autor:
Shijia Li, Jianrong Ge, Shiyuan Zhou, Wenjuan Zhu, Yue Han, Suning Chen, Shengli Xue, Ying Wang, Huiying Qiu, Xiaojin Wu, Depei Wu
Publikováno v:
Clinical and Translational Medicine, Vol 13, Iss 10, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/a148a6f2f9274b1e8ad6f83b1fa38cb7
Autor:
Zheng LI, Hao Zhang, Yanyan LI, Lulu Chen, Haiping Dai, Haixia Zhou, Mingzhu Xu, Tongtong Zhang, Chongsheng Qian, Wenjie Gong, Qiaocheng Qiu, Aining Sun, Depei Wu, Shengli Xue
Publikováno v:
HemaSphere, Vol 7, p e204697f (2023)
Externí odkaz:
https://doaj.org/article/518dc994715d42fa895962ceb0a82f54
Autor:
Jingwen Tan, Yujie Jia, Meixia Zhou, Chengcheng Fu, Israth Jahan Tuhin, Jing Ye, Masuma Akter Monty, Nan Xu, Liqing Kang, Minghao Li, Jiaqi Shao, Xiaoyan Fang, Hongjia Zhu, Lingzhi Yan, Changju Qu, Shengli Xue, Zhengming Jin, Suning Chen, Haiwen Huang, Yang Xu, Jia Chen, Miao Miao, Xiaowen Tang, Caixia Li, Zhiqiang Yan, Depei Wu, Lei Yu
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-6 (2022)
Abstract Persistence of CAR-T cell function is associated with relapse rate after CAR-T therapy, while co-stimulatory agents are highly concerned with the persistence of CAR-T cells. In this study, we designed and constructed a series of BCMA-targeti
Externí odkaz:
https://doaj.org/article/a3ee58789e894f47809e3f878bf84545
Autor:
Jingxian Gu, Sining Liu, Wei Cui, Haiping Dai, Qingya Cui, Jia Yin, Zheng Li, Liqing Kang, Huiying Qiu, Yue Han, Miao Miao, Suning Chen, Shengli Xue, Ying Wang, Zhengming Jin, Xiaming Zhu, Lei Yu, Depei Wu, Xiaowen Tang
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Background/AimsChimeric antigen receptor (CAR) T cells for refractory or relapsed (r/r) B-cell acute lymphoblastic leukemia (ALL) patients have shown promising clinical effectiveness. However, the factors impacting the clinical response of CAR-T ther
Externí odkaz:
https://doaj.org/article/a944e1cba69d4ba8b716cb889307f8e2